| HOME >> BIOLOGY >> TECHNOLOGY |
(Unaudited)
Assets:
Current Assets:
Cash and cash equivalents $2,218,246 $559,017
Inventory, net of reserve for
obsolescence - 1,556
Prepaid expenses and
other current assets 74,484 12,994
Total current assets 2,292,730 573,567
Property and Equipment, at cost:
Computer equipment 248,272 245,694
Office and laboratory equipment 590,926 590,926
Furniture and fixtures 14,288 14,288
Manufacturing equipment 197,888 197,888
Leasehold improvements 177,768 177,768
1,229,142 1,226,564
Less-Accumulated depreciation and
amortization (1,105,441) (1,017,051)
Net property and equipment 123,701 209,513
Other Assets:
Restricted cash 10,250 19,949
Deposits and other assets 2,000 2,000
Intangible assets, net 10,420,000 -
Total other assets 10,432,250 21,949
Total assets $12,848,681 $805,029
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts payable $363,057 $45,817
Deferred revenue 8,333 45,833
Current portion of notes payable,
net of unamortized discount 55,208 89,808
Accrued expenses
'/>"/>
| SOURCE Echo Therapeutics, Inc. Copyright©2007 PR Newswire. All rights reserved |